Goh George Boon-Bee, Chang Pik-Eu, Tan Chee-Kiat
Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore; Duke-NUS Graduate Medical School, Singapore.
Best Pract Res Clin Gastroenterol. 2015 Dec;29(6):919-28. doi: 10.1016/j.bpg.2015.09.007. Epub 2015 Sep 10.
Hepatocellular carcinoma is a major problem in Asia because of the presence of multiple risk factors in the region such as endemicity of hepatitis B and significant contamination of foodstuff by aflatoxin in some areas. Another risk factor for HCC, chronic hepatitis C infection, in Asia is most significant in Japan, the only Asian country with more HCV than HBV-related hepatocellular carcinoma. As these risk factors can and are being modified by measures such as universal hepatitis B immunisation, successful treatment of HCV infections, reduction and improved surveillance of aflatoxin contamination of foodstuff, it is not surprising that the epidemiology of HCC in Asia is changing. All these are offset by the rising importance of NAFLD and NASH as chronic liver diseases and risk factors for HCC which contributes to the changing epidemiology of HCC in Asia.
肝细胞癌在亚洲是一个主要问题,因为该地区存在多种风险因素,如乙型肝炎的地方性流行以及某些地区黄曲霉毒素对食品的严重污染。肝细胞癌的另一个风险因素——丙型肝炎病毒慢性感染,在亚洲,日本最为显著,日本是唯一一个丙型肝炎病毒相关肝细胞癌比乙型肝炎病毒相关肝细胞癌更多的亚洲国家。由于这些风险因素可以而且正在通过诸如普遍接种乙型肝炎疫苗、成功治疗丙型肝炎病毒感染、减少并改善对食品中黄曲霉毒素污染的监测等措施得到改善,所以亚洲肝细胞癌的流行病学正在发生变化也就不足为奇了。非酒精性脂肪性肝病和非酒精性脂肪性肝炎作为慢性肝病和肝细胞癌的风险因素,其重要性日益增加,抵消了上述所有因素,这也导致了亚洲肝细胞癌流行病学的变化。